We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
-4.61%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.42B
AUM Growth
-$122M
(-4.8%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
32.13%
Holding
794
New
116
Increased
220
Reduced
211
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$70.6M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$50.4M |
| 3 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$31.1M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$17.6M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$69.2M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$60.8M |
| 3 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$26.1M |
| 4 |
First Trust Senior Loan Fund ETF
FTSL
|
+$15.1M |
| 5 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 8.88% |
| 3 | Financials | 6.63% |
| 4 | Consumer Discretionary | 4.47% |
| 5 | Industrials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
601
DELISTED
Veren
VRN
| $203K | 0.01% |
+33,000
| New | +$236K |
|
602
Capricor Therapeutics
CAPR
$1.15B
| $202K | 0.01% |
33,601
+3,800
| +13% | +$19.4K |
|
603
iShares Silver Trust
SLV
$27.8B
| $198K | 0.01% |
+11,297
| New | +$200K |
|
|
MFA
604
MFA Financial
MFA
$921M
| $197K | 0.01% |
25,300
-24,976
| -50% | -$279K |
|
605
Modine Manufacturing
MOD
$13.3B
| $196K | 0.01% |
+15,157
| New | +$213K |
|
606
Richardson Electronics
RELL
$318M
| $189K | 0.01% |
+12,500
| New | +$197K |
|
|
ARI
607
Apollo Commercial Real Estate
ARI
$885M
| $188K | 0.01% |
22,640
| – | – |
|
608
AT&T
T
$157B
| $187K | 0.01% |
12,162
+242
| +2% | +$4.4K |
|
609
Snap
SNAP
$7.42B
| $186K | 0.01% |
18,974
| – | – |
|
610
CareTrust REIT
CTRE
$10B
| $181K | 0.01% |
10,000
| – | – |
|
611
Annexon
ANNX
$868M
| $180K | 0.01% |
29,086
| – | – |
|
612
SLM Corp
SLM
$4.56B
| $175K | 0.01% |
+12,522
| New | +$194K |
|
|
KLRS
613
Kalaris Therapeutics
KLRS
$93.3M
| $173K | 0.01% |
952
| – | – |
|
614
Utz Brands
UTZ
$1.25B
| $172K | 0.01% |
+11,400
| New | +$185K |
|
615
Macy's
M
$6.14B
| $171K | 0.01% |
+10,900
| New | +$193K |
|
616
Voyager Therapeutics
VYGR
$187M
| $171K | 0.01% |
+28,900
| New | +$185K |
|
|
ETNB
617
DELISTED
89bio
ETNB
| $167K | 0.01% |
28,892
-800
| -3% | -$3.52K |
|
|
KZR
618
DELISTED
Kezar Life Sciences
KZR
| $164K | 0.01% |
+1,902
| New | +$185K |
|
619
Banco Bilbao Vizcaya Argentaria
BBVA
$140B
| $151K | 0.01% |
33,994
+2,073
| +6% | +$9.41K |
|
|
PCTI
620
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $149K | 0.01% |
+31,547
| New | +$150K |
|
621
Ironwood Pharmaceuticals
IRWD
$624M
| $140K | 0.01% |
13,500
| – | – |
|
622
Viatris
VTRS
$20.1B
| $140K | 0.01% |
16,456
| – | – |
|
623
Puma Biotechnology
PBYI
$408M
| $127K | 0.01% |
53,500
| – | – |
|
|
PRPH
624
DELISTED
ProPhase Labs
PRPH
| $126K | 0.01% |
+1,120
| New | +$130K |
|
625
Allogene Therapeutics
ALLO
$628M
| $125K | 0.01% |
+11,600
| New | +$158K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q3 2022 Portfolio in Review
As of Q3 2022, Bailard held 794 positions worth $2.42B, down 4.8% from $2.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bailard's Q3 2022 filing shows 116 new, 220 increased, 211 reduced and 134 closed positions. Its largest new stake was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $69.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q3 2022 buy was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M.
- Bailard added most to iShares 1-3 Year Treasury Bond ETF in Q3 2022, an estimated $70.6M increase.
- Bailard's biggest Q3 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $69.2M.
- Bailard fully exited First Trust Senior Loan Fund ETF in Q3 2022, selling an estimated $15.1M.
- Bailard's ten largest holdings make up 32% of its $2.42B portfolio in Q3 2022.
- Bailard opened 116 new positions and closed 134 in Q3 2022.
- Bailard's portfolio value fell 4.8% quarter-over-quarter to $2.42B.
Based on Bailard's 13F filing for Q3 2022, filed 18 Oct 2022.